I'm glad to see more information out on CTIX, but, there's quite the misstatement in there:

"the "Guardian Angel of the Human Genome" which has been shown in Phase I trials to reduce tumor size and progression when other cancer-fighting drugs simply failed"

The price would have skyrocketed if that were correct.